URO ONCO

Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Anxiety in the management of localised prostate cancer by active surveillance

BJU Int. 2014 Nov;114 Suppl 1:55-61.

BJU Int. 2014 Nov;114 Suppl 1:55-61.

Abstract

OBJECTIVES:

To describe a range of anxieties in men on active surveillance (AS) for prostate cancer and determine which of these anxieties predicted health-related quality of life (HRQL).

PATIENTS AND METHODS:

In all, 260 men with prostate cancer on AS were invited to complete psychological measures including the Hospital and Anxiety Depression Scale; the State-Trait Anxiety Inventory-Trait Scale; the Memorial Anxiety Scale for Prostate Cancer; and the Functional Assessment of Cancer Therapy Scale-Prostate. Overall, 86 men with a mean (sd, range) age of 65.7 (5.4, 51-75) years returned data, yielding a response rate of 33%. Outcome measures were standardised psychological measures. Pearson's correlations were used to examine bivariate relationships, while regression analyses were used to describe predictors of dependent variables.

RESULTS:

When compared with the findings of prior research, the men in our cohort had normal levels of general anxiety and illness-specific anxiety and high prostate cancer-related HRQL. Age, trait anxiety and fear of recurrence (FoR) were significant predictors of prostate cancer-related HRQL; trait anxiety and FoR were significant predictors of total HRQL. Results should be interpreted in context of sample characteristics and the correlational design of the study.

CONCLUSIONS:

Participants reported low levels of anxiety and high HRQL. Trait anxiety and FoR were significant predictors of both prostate cancer-related and total HRQL. The administration of a short trait-anxiety screening tool may help identify men with clinically significant levels of anxiety and those at risk of reduced HRQL.

© 2014 The Authors. BJU International © 2014 BJU International.

KEYWORDS:

active surveillance; anxiety; health-related quality of life (HRQL); prostate cancer

Comment from Henk van der Poel: Anxiety levels in men on active surveillance for low risk prostate cancer were low. In this study response rate was disturbingly low (33%), but of the men that did show a QOL rsponse, it was high. It remains unclear whether the majority of men did not response because of disinterest or anxiety. It would be interesting to assess anxiety in those men that will experience progression and secondary need for local treatment.

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe

URO ONCO is made possible by an unrestricted educational grant from:

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.

The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.